KNOBELMAN DEBORAH (Chief Financial Officer) sold 15.1% of their position (24.84K shares) of KRONOS BIO, INC. on the open market
Open‑market sale worth $21.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/6/2025ACC: 0001415889-25-016003
Officer· Chief Financial Officer
Since Jun 2024
-24.84K
Net shares
Net seller
$21.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
24.84K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−24.84K
Price / share
$0.87
Trade value
$21.55K
% of position
15.1%
6/5/2025
164.26K→139.42K
Total
Net shares
−24.84K
Net value
-$21.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2025 | S · Sale | −24.84K | $0.87 | $21.55K | 15.1% | 164.26K | 139.42K |
| Total | −24.84K | -$21.55K | ||||||
Derivative Transactions0
No derivative transactions reported